tbuckley/cabot-search huggingface dataset:
ONE WAY OF DOING IT.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Can the practice of medicine be fun for a lifetime?
Authors: S. B. Guze
Journal: JAMA (1979)

THERE are four kinds of satisfaction to be derived from medicine: prestige, income, helping to relieve suffering, and intellectual effort. Despite widespread criticism of the profession, society recognizes the important contributions of medicine, and individual physicians are afforded a position in the community second to none. Respect, special privileges and considerations, and deference are the experience of nearly all doctors of medicine, who also enjoy incomes among the highest in the community. Few physicians are immune to the pleasures and benefits of money and prestige. After many years of intense competition and hard work, such rewards are sweet indeed. They begin to justify the effort and the sacrifices without which no one can become a physician. Few of us fail to respond with pleasure to being called "Doctor," and it is gratifying to be able to afford the nice things in life. We like to pay off our debts, buy
Selected Characteristics of Black Physicians in the United States, 1972
Authors: Theodis Thompson
Journal: JAMA (1975)

<h3>To the Editor.—</h3> The letter by Mr. Stambler points out two observations that I have made in subsequent discussions about my article: (1) The data reported are<i>not</i>generalizable to the universe of black physicians in the United States. (2) The pretest, phase 1, was a stratified sample (p 1758); phase 2, the universe study, (by definition) was not a sample study. The findings reported are based on the responses to 3,405 usable, mailed questionnaires. Moreover, data for the number of physicians by states, for example, should not be considered the actual number of physicians, but the number of physicians<i>responding</i>to the particular survey from a given state. I agree with Mr. Stambler that the data reported should not be used for making erroneous inferences about the characteristics of black physicians in the United States in 1972. However, the data tables used in the study were generated by the
Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol‐5D response of biological treatment in psoriasis: 10 years of real‐world data in the Swedish National Psoriasis Register
Authors: F. Hjalte, K.S. Carlsson, M. Schmitt‐Egenolf
Journal: British Journal of Dermatology (2018)

Patients with mild disease are usually treated with topical treatments, meaning applied to the skin, while patients with moderate to severe disease require systemic treatments (taken inside the body), which includes drugs called biologics. PsoReg is the Swedish national register established in 2006 to monitor the long term effectiveness and safety of biologics. PsoReg records patients’ Psoriasis Area and Severity Index (PASI), which is a way of measuring how severe and widespread a patient's psoriasis is at a given time, allowing doctors to see if symptoms are worsending or improving. PsoReg also records patients’ Health‐Related Quality of Life (HRQoL), which takes into account how the disease is affecting their daily activities and emotional wellbeing. This study used data from 583 patients to see how switching to a biologic treatment, having not previously taken biologics, impacts on their PASI and HRQoL. PASI and HRQoL values were analysed at 3–5 months, 6–11 months, and at least once more after a year or more, up to 9 years after switch to biological treatment. The data showed significant improvement in these scores 3–5 months after the switch, and this improvement lasted the whole observation period. The results from this study may support clinicians in starting and continuing biological treatment for patients with disappointing results with other types of treatment.
Health Status of Vietnam Veterans
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Experiences with Hypothermia and Hypotension in Major Head and Neck Surgery
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Excision of a renal cell carcinoma in a solitary kidney
Authors: T. F. Kaiser
Journal: JAMA (1968)

A renal cell carcinoma in the midportion of a solitary kidney was successfully excised in a 42-year-old woman. Selective renal angiography was invaluable in preoperative planning. Mannitol, administered intravenously, was given during surgery to prevent postoperative renal failure following temporary renal artery occlusion.
Obesity
Authors: Susan Z. Yanovski, Jack A. Yanovski
Journal: New England Journal of Medicine (2002)

The most common nutritional disorders in the United States are overweight and obesity. This review discusses the treatment of overweight and obesity as chronic conditions that require a combined approach of behavioral therapy, exercise, dietary changes, and — in certain cases — medication. The authors consider the three classes of weight-loss drugs: those that suppress appetite, those that decrease nutrient absorption, and those that increase energy expenditure. Currently available and soon-to-be-released drugs are discussed.
BOOK REVIEWS
Authors: J. A. PETREK
Journal: JNCI Journal of the National Cancer Institute (1992)

BOOK REVIEWS Get access The Operative Management of Breast Disease R. Robinson Baker , John Niederhuber . Philadelphia : W. B. Saunders , 1992 . 135 pp., illus. $125. ISBN 0-7216-2960-1 JEANNE A. PETREK, M.D. JEANNE A. PETREK, M.D. Breast Service Memorial Sloan-Kettering Cancer Center 1275 York AveNew York, NY 10021 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 84, Issue 22, 18 November 1992, Page 1751, https://doi.org/10.1093/jnci/84.22.1751 Published: 18 November 1992
MORSICATIO BUCCARUM.*
Authors: E. KOCSARD, L. SCHWARZ, B. S. STEPHEN, V. St. E. D'Abrera
Journal: British Journal of Dermatology (1962)

Journal Article MORSICATIO BUCCARUM. Get access E. KOCSARD, M.D., D.D.M., E. KOCSARD, M.D., D.D.M. Sydney, Australia Search for other works by this author on: Oxford Academic Google Scholar L. SCHWARZ, M.D., D.D.S., L. SCHWARZ, M.D., D.D.S. Sydney, Australia Search for other works by this author on: Oxford Academic Google Scholar B. S. STEPHEN, M.B., Ch. B., D.P., B. S. STEPHEN, M.B., Ch. B., D.P. Sydney, Australia Search for other works by this author on: Oxford Academic Google Scholar V. St. E. D'Abrera, M.D., D.C.P., D.T.M. & H., M.C.P.A. V. St. E. D'Abrera, M.D., D.C.P., D.T.M. & H., M.C.P.A. Sydney, Australia Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 74, Issue 12, 1 December 1962, Pages 454–457, https://doi.org/10.1111/j.1365-2133.1962.tb13445.x Published: 01 December 1962
BERLIN LETTER.
Authors: None H. R. B.
Journal: JAMA (1885)

Berlin, Nov. 24, 1884. <h3>Wandering Kidney — Hydronephrosis — Perinephritic Abscess—Abdominal Fistula.</h3> —In my last letter I mentioned a case of wandering kidney which I saw at the poli-klinik of Dr. Leopold Landau, Privat Docent. There is so much of general interest in this subject, and so much of especial merit in this case that I translate its history from " Die Wanderniere der Frauen"—a small brochure too little known in America, and yet one in which the whole subject is reviewed by Dr. Landau in a masterly manner: "C. M., 60 years old, has borne two children, one at forty and the other thirty-six years age. At her last confinement she had a prolapse of the uterus. For the last ten years she has suffered from pain in the loins, constant uneasiness in the abdomen, cardialgia, gastric derangement, dragging pain in the loins and pressure upon the bladder. About eight
RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development
Authors: Rakesh Verma, Su Su, Donald J. McCrann, Jennifer M. Green, Karen Leu, Peter R. Young, Peter J. Schatz, Jeffrey C. Silva, Matthew P. Stokes, Don M. Wojchowski
Journal: The Journal of Experimental Medicine (2014)

Ligation of erythropoietin (EPO) receptor (EPOR) JAK2 kinase complexes propagates signals within erythroid progenitor cells (EPCs) that are essential for red blood cell production. To reveal hypothesized novel EPOR/JAK2 targets, a phosphotyrosine (PY) phosphoproteomics approach was applied. Beyond known signal transduction factors, 32 new targets of EPO-modulated tyrosine phosphorylation were defined. Molecular adaptors comprised one major set including growth factor receptor-bound protein 2 (GRB2)–associated binding proteins 1–3 (GAB1-3), insulin receptor substrate 2 (IRS2), docking protein 1 (DOK1), Src homology 2 domain containing transforming protein 1 (SHC1), and sprouty homologue 1 (SPRY1) as validating targets, and SPRY2, SH2 domain containing 2A (SH2D2A), and signal transducing adaptor molecule 2 (STAM2) as novel candidate adaptors together with an ORF factor designated as regulator of human erythroid cell expansion (RHEX). RHEX is well conserved in Homo sapiens and primates but absent from mouse, rat, and lower vertebrate genomes. Among tissues and lineages, RHEX was elevated in EPCs, occurred as a plasma membrane protein, was rapidly PY-phosphorylated &amp;gt;20-fold upon EPO exposure, and coimmunoprecipitated with the EPOR. In UT7epo cells, knockdown of RHEX inhibited EPO-dependent growth. This was associated with extracellular signal-regulated kinase 1,2 (ERK1,2) modulation, and RHEX coupling to GRB2. In primary human EPCs, shRNA knockdown studies confirmed RHEX regulation of erythroid progenitor expansion and further revealed roles in promoting the formation of hemoglobinizing erythroblasts. RHEX therefore comprises a new EPO/EPOR target and regulator of human erythroid cell expansion that additionally acts to support late-stage erythroblast development.
POISONING IN HISTORY.
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
In vitro Assessment of Equivalence of Occupational Health Risk: Welders
Authors: R. M. Stern
Journal: Environmental Health Perspectives (1983)

The possibility of using in vitro testing to determine the equivalence of risk for various occupational groups is discussed. In the absence of epidemiological evidence or relevant animal in vivo bioassays on which to determine the health effects of specific occupational exposures, it is proposed to use similarities in the in vitro response to substances with known (or strongly suspected) and unknown risk to demonstrate their risk equivalence. Identification and evaluation of a high risk "hot spot" due to exposure to Cr(VI) for stainless steel welders is discussed in terms of recent developments in collection, analysis and bioassay of welding fumes.
Erratum: Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1
Authors: Omar D Perez, Dennis Mitchell, Gina C Jager, Sharon South, Chris Murriel, Jacqueline McBride, Lee A Herzenberg, Shigemi Kinoshita, Garry P Nolan
Journal: Nature Immunology (2003)
BELGIUM
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Norepinephrine analog detects pheochromocytoma
Authors: B. Bolsen
Journal: JAMA (1982)

Investigators at the University of Michigan Medical School, Ann Arbor, have developed a radiopharmaceutical agent that permits the identification of pheochromocytomas—hypertension-causing tumors of the sympathetic autonomic nervous system—by scintigraphy. The drug,<sup>131</sup>I-metaiodobenzylguanadine (<sup>131</sup>I-MIBG), is structurally similar to the neurotransmitter norepinephrine and follows its pathway to the sympathetic nerves, according to James C. Sisson, MD, professor of internal medicine. "The drug is avidly taken up by sympathetic nervous tissue," Sisson said, but in greater concentrations by the tumors than by small nerves or the adrenal glands. Thus, "we see no normal tissues; we look only at pheochromocytomas." Using<sup>131</sup>I-MIBG and scintigraphy, Sisson and co-workers located the vascular tumors in all but three of 40 patients with difficult-to-locate lesions. In comparison, computed tomography (CT) successfully located tumors in fewer than half of the same group, Sisson said at a recent American Cancer Society seminar. Most pheochromocytomas are located in
Continuous ambulatory esophageal pH monitoring in the evaluation of patients with gastroesophageal reflux. Diagnostic and Therapeutic Technology Assessment
Journal: JAMA (1995)

<h3>Objective.</h3> —To provide clinicians with a technology assessment of the safety and effectiveness of continuous ambulatory esophageal pH monitoring (CAEpHM) in the diagnosis of pathologic gastroesophageal reflux in adults. <h3>Participants.</h3> —A literature review and a Diagnostic and Therapeutic Technology Assessment (DATTA) survey questionnaire were mailed to 118 physicians with special interest in gastroesophageal reflux, esophageal disease, or the use of CAEpHM in the diagnosis of noncardiac chest pain. These panelists had been nominated to the DATTA panel by appropriate specialty societies and medical schools. A total of 93 panelists (79%) responded. <h3>Evidence.</h3> —Assessment was based on the expert opinion of the panelists, as well as on published scientific and medical literature (available as of June 1, 1994). Published studies were identified by a MEDLINE search using the terms<i>esophagitis, reflux</i>, and<i>gastroesophageal reflux</i>and by review of the references cited in these primary sources. <h3>Consensus Process.</h3> —The respondents completed a DATTA survey questionnaire; the survey results were tabulated, analyzed, and interpreted by an American Medical Association medical scientist. <h3>Conclusions.</h3> —The safety of CAEpHM was considered to be established in adults with chronic heartburn, chronic hoarseness, persistent acid reflux refractory to therapy, laryngeal lesions, or noncardiac substernal chest pain. The safety of CAEpHM was considered to be promising in adults with episodes of apnea. The effectiveness of CAEpHM was considered to be established in adult patients with clear primary symptoms that reflect esophageal damage, such as chronic heartburn, persistent acid reflux refractory to therapy, or noncardiac substernal pain; promising in adults with chronic hoarseness; and investigational in adults with episodes of apnea. (<i>JAMA</i>. 1995;274:662-668)
Practical Orthodontia.
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE MODE OF ACTION OF ANTISTREPTOCOCCUS SERUM.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAPAN
Journal: JAMA (1961)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal